Asthma Inhalers with Salmeterol Deaths

Three common asthma inhalers containing the drugs salmeterol or formoterol may be causing four out of five U.S. asthma-related deaths per year and should be taken off the market, researchers from Cornell and Stanford Universities have concluded after a search of medical literature. They base these conclusions on a statistical analysis of 19 published trials involving 33,826 patients. NOTE: that no Advair Recall or Serevent Recall or Foridil Recall has been announced or planned by the FDA.

Asthma Deaths

This so-called meta-analysis found that patients who inhaled the long-acting beta-agonists salmeterol (trade names Serevent and Advair, both made by GlaxoSmithKline) or formoterol (trade name Foradil, made by Novartis Pharmaceuticals) were 3.5 times more likely to die from asthma and 2.5 times more likely to be hospitalized (whether or not death resulted), compared with those taking a placebo.

Asthma Inhaler Death Lawsuit

If you have lost a loved one due to an asthma inhaler death, then call and call the Willis Law Firm at 1-800-883-9858 for a Free Asthma Inhaler Lawsuit Consultation.